Avinger, Inc. Executes Assignment for the Benefit of Creditors; Announces Receipt of Nasdaq Delisting Notice
Avinger, Inc. (AVGR) Q3 2024 Earnings Call Transcript
Avinger (AVGR) Reports Q3 Loss, Tops Revenue Estimates
Avinger Reports Third Quarter 2024 Results
Avinger to Announce Third Quarter 2024 Results on November 7, 2024
Avinger Releases Updated Data From IMAGE-BTK in Webinar Featuring Key Opinion Leaders in the Field of Vascular Intervention
Avinger Announces Issuance of New U.S. Patent and Receives Notices of Allowance for Five Additional U.S. Patents
Avinger (AVGR) Launches Pantheris LV to Boost PAD Treatment
Avinger Initiates Full Commercial Launch of Pantheris LV Image-Guided Atherectomy Device
Avinger, Inc. (AVGR) Q2 2024 Earnings Call Transcript
Avinger (AVGR) Reports Q2 Loss, Lags Revenue Estimates
Avinger Reports Second Quarter 2024 Results
Avinger Appoints Thomas P. Davis, MD, FACC as Chief Medical Officer
Avinger to Announce Second Quarter 2024 Results on August 8, 2024
Avinger Announces Closing of up to $24 Million Public Offering
Avinger Increases Focus on Coronary Development, Reduces Operating Costs of Peripheral Business
Are Medical Stocks Lagging Avinger (AVGR) This Year?
Avinger Announces Conversion of $11 Million of CRG Debt into Preferred Equity
Avinger, Inc. (AVGR) Q1 2024 Earnings Call Transcript
Avinger Reports First Quarter 2024 Results
Avinger to Announce First Quarter 2024 Results on May 15, 2024
Fast-paced Momentum Stock Avinger (AVGR) Is Still Trading at a Bargain
Avinger (AVGR) Upgraded to Buy: What Does It Mean for the Stock?
Avinger, Inc. (AVGR) Q4 2023 Earnings Call Transcript
Avinger Reports Fourth Quarter and Full Year 2023 Results
Avinger to Announce Full Year 2023 Results on March 20, 2024
Zylox-Tonbridge and Avinger Forge Strategic Partnership to Expand Disruptive OCT Solutions for Peripheral Vascular Interventions
Avinger Announces Strategic Partnership and up to $15 Million Equity Funding Agreement with Zylox-Tonbridge
Avinger (AVGR) Reports Q3 Loss, Lags Revenue Estimates
Avinger, Inc. (AVGR) Q3 2023 Earnings Call Transcript
Avinger Reports Third Quarter 2023 Results
Avinger to Announce Third Quarter 2023 Results on October 26
Avinger Raises $5.3 Million via At-The-Market Facility
Avinger stock rockets off a record low after launch of vascular disease treatment system
Avinger Initiates Full Commercial Launch of Tigereye ST Image-Guided CTO Crossing Device
Avinger Announces Presentations by Key Opinion Leaders at AMP (The Amputation Prevention Symposium) 2023
Avinger Announces Conversion of 12% of CRG Term Debt into Equity
Avinger, Inc. (AVGR) Q2 2023 Earnings Call Transcript
Avinger (AVGR) Reports Q2 Loss, Misses Revenue Estimates
Avinger Reports Second Quarter 2023 Results
Avinger to Announce Second Quarter 2023 Results on July 27
Avinger, Inc. (AVGR) Q1 2023 Earnings Call Transcript
Avinger to Announce First Quarter 2023 Results on May 10
Top Penny Stocks To Buy? 4 Under $1 To Watch This Week
Avinger, Inc (AVGR) Q4 2022 Earnings Call Transcript
Avinger to Announce Fourth Quarter 2022 Results on March 15
Avinger, Inc (AVGR) Q3 2022 Earnings Call Transcript
Avinger to Announce Third Quarter 2022 Results on November 9
Avinger to Present at LD Micro Investor Conference
Avinger, Inc.'s (AVGR) CEO Jeff Soinski on Q2 2022 Results - Earnings Call Transcript